MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications
Muller Fabbri(The University of Texas MD Anderson Cancer Center), George A. Calin(The University of Texas MD Anderson Cancer Center), Ramiro Garzon(Unknown), Guillermo Garcia‐Manero(The University of Texas MD Anderson Cancer Center), Michael Andreeff(The University of Texas MD Anderson Cancer Center), H. Kantarjian(The University of Texas MD Anderson Cancer Center)
Cited by 145
Related Papers
MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
|JAMA|2008|1.6k
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias
|Proceedings of the National Academy of Sciences|2004|1.3k
Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia
|Journal of Clinical Oncology|2005|951